Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
PBH · NYSE · United States · Pharmaceutical Preparations
In shortPrestige Consumer Healthcare Inc. is profitable, generates cash and carries moderate debt, with revenue shrinking (−4.3% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 28.4% | 100/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 17.5% | 90/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 10.2% | 51/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 7.9% | 53/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 3.57× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.53× | 82/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 2.73× | 36/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 4.04 | 75/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 22.6% | 100/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 1.30× | 100/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 4 of 5 | 80/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 7.4% | 84/100 |
| Operating margin volatility | 14.2% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -1.2% | 10/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2026 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 1,087 | 1,128 | 1,125 | 1,138 | 1,089 |
| Cost of revenue | 466 | 502 | 501 | 503 | 493 |
| Gross profit | 621 | 625 | 624 | 634 | 596 |
| Operating income | 330 | (22) | 342 | 337 | 309 |
| Interest expense | 64 | 4.4 | 5.2 | 1.8 | – |
| Pre-tax income | 262 | (94) | 276 | 284 | 257 |
| Income tax | 57 | (12) | 67 | 70 | 67 |
| Net income | 205 | (82) | 209 | 215 | 190 |
| Diluted EPS | $4.04 | −$1.65 | $4.17 | $4.29 | $3.91 |
| Diluted shares (millions) | 51 | 50 | 50 | 50 | 49 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of Prestige Consumer Healthcare Inc. are included in the Investor plan. Try free for 7 days →
4.04 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 6, 2026